3) d-dimensional nearest-neighbor RWRE
d维最近领域RWRE
4) R & D
R&D
1.
Influences and Measures to Our Technological Innovation of R & D Investment in China by Transnational Corporation;
跨国公司在华R&D投资对我国技术创新的影响及对策分析
2.
The Application of Real Option to Investment Evaluation of R & D Projects;
实物期权在R&D项目投资评价中的应用
3.
R & D of Multinational Corporations in China and the Technological Innovation of Chinese Enterprises
跨国公司在华R&D与中国企业技术创新
5) R D
R-D
6) Research and Development
R&D
1.
<Abstrcat> The present paper sets out to study the cost-reimbursement of manufactures research and development in defense procurement and analyzes the efficiencies of different models based on cost-reimbursement.
对国防采购中厂商的R&D成本补偿问题进行了研究,分析了不同成本补偿模型的效率,所得结论表明:为了激励厂商创新,军方需向厂商的研究与发展提供补偿;军方补偿方式的效率与从事国防项目研究与发展的厂商的风险态度有关。
2.
The manufactures behaviors in research and development in defense procurement was studied.
研究了国防采购中厂商对国防研究与发展(R&D)项目的投资行为,探讨了军方如何通过对国防R&D项目投资补偿比例的选择来调控厂商的投资决策。
3.
The present paper sets out to study the models of research and development cost-reimbursement in defense procurement and investigate a new model of R&D cost-reimbursement that compensate the manufactures for their R&D cost based on quotas.
本文对国防采购中R&D成本补偿模型进行研究,提出了一种新的R&D成本补偿方式———基于定额的R&D成本补偿模型,并对其特性进行探讨,所得结论表明:定额补偿模型不仅形式简单,具有效率,而且在一定条件下具有优良的均衡特性,使得军方可对厂商的投资行为进行控制。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条